TGF- β signaling in cancer – a double-edged sword
Data up to Jan 2025
Total Citations Per Year
Abstract
References (73)
Mutation and Cancer: Statistical Study of Retinoblastoma
1971 • 7,335 citations
TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
2000 • 2,354 citations
Growth factors from murine sarcoma virus-transformed cells.
1978 • 1,457 citations
Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1
1994 • 1,452 citations
Cyclosporine induces cancer progression by a cell-autonomous mechanism
1999 • 1,119 citations
Defective haematopoiesis and vasculogenesis in transforming growth factor-β1 knock out mice
1995 • 1,020 citations
A mechanism of repression of TGFbeta / Smad signaling by oncogenic Ras
1999 • 1,004 citations
Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells
1987 • 998 citations
Transforming Growth Factor-β1 Mediates Epithelial to Mesenchymal Transdifferentiation through a RhoA-dependent Mechanism
2001 • 993 citations
TGF-β signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development
1999 • 969 citations
TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors.
1994 • 937 citations
Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors.
1987 • 895 citations
Defective Angiogenesis in Mice Lacking Endoglin
1999 • 851 citations
Activin receptor-like kinase 1 modulates transforming growth factor-β1 signaling in the regulation of angiogenesis
2000 • 823 citations
Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells.
1994 • 702 citations
TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells.
1996 • 680 citations
TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway
1999 • 667 citations
TGF-β Receptor Type II Deficiency Results in Defects of Yolk Sac Hematopoiesis and Vasculogenesis
1996 • 651 citations
TGFβ signaling is necessary for carcinoma cell invasiveness and metastasis
1998 • 630 citations
TGFβ1 Inhibits the Formation of Benign Skin Tumors, but Enhances Progression to Invasive Spindle Carcinomas in Transgenic Mice
1996 • 619 citations
Phenotypic modulation of endothelial cells by transforming growth factor-beta depends upon the composition and organization of the extracellular matrix.
1988 • 571 citations
Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice
2001 • 549 citations
A role for Smad6 in development and homeostasis of the cardiovascular system
2000 • 488 citations
TGFβ influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b
2001 • 479 citations
A murine model of hereditary hemorrhagic telangiectasia
1999 • 472 citations
Arteriovenous malformations in mice lacking activin receptor-like kinase-1
2000 • 438 citations
Endoglin, an Ancillary TGFβ Receptor, Is Required for Extraembryonic Angiogenesis and Plays a Key Role in Heart Development
2000 • 433 citations
TGF-β type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells
1999 • 419 citations
A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance.
1990 • 409 citations
Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential.
1990 • 398 citations
Angiogenesis defects and mesenchymal apoptosis in mice lacking SMAD5
1999 • 394 citations
Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15Ink4B transcription in response to TGF-β
2000 • 392 citations
Regulation of the Proinflammatory Effects of Fas Ligand (CD95L)
1998 • 391 citations
ELEVATED LEVELS OF CIRCULATING INTERLEUKIN-6 AND TRANSFORMING GROWTH FACTOR-beta 1 IN PATIENTS WITH METASTATIC PROSTATIC CARCINOMA
1999 • 379 citations
Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.
1993 • 356 citations
TGF-β-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation
2001 • 350 citations
Macrophage-derived angiogenesis factors
1991 • 325 citations
Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor beta.
1988 • 324 citations
Enhanced Tumorigenicity and Invasion-Metastasis by Hepatocyte Growth Factor/Scatter Factor-Met Signalling in Human Cells Concomitant with Induction of the Urokinase Proteolysis Network
1996 • 312 citations
Transforming growth factor β1 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancer
1998 • 311 citations
Raf induces TGFβ production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells
2000 • 292 citations
High levels of transforming growth factor beta 1 in patients with colorectal cancer: Association with disease progression
1996 • 285 citations
Spindle cell carcinoma.Ultrastructural evidence of squamous origin and collagen production by the tumor cells
1976 • 284 citations
Localized production of TGF-β mRNA in tumour promoter-stimulated mouse epidermis
1988 • 275 citations
Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis
1998 • 263 citations
Microsatellite instability and the role of hMSH2 in sporadic colorectalcancer.
1996 • 252 citations
The Activin Receptor-Like Kinase 1 Gene: Genomic Structure and Mutations in Hereditary Hemorrhagic Telangiectasia Type 2
1997 • 241 citations
Epithelial cell plasticity in development and tumor progression.
1999 • 197 citations
Transforming growth factor beta is essential for spindle cell conversion of mouse skin carcinoma in vivo: implications for tumor invasion.
1998 • 189 citations
Transforming growth factor beta 1 (TGF-beta 1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-beta 1 null mouse phenotype.
1993 • 181 citations
The motility signal of scatter factor/hepatocyte growth factor mediated through the receptor tyrosine kinase met requires intracellular action of Ras.
1994 • 175 citations
Targeted Disruption in Murine Cells Reveals Variable Requirement for Smad4 in Transforming Growth Factor β-related Signaling
2000 • 161 citations
Excessive production of transforming growth-factor β1 can play an important role in the development of tumorigenesis by its action for angiogenesis: validity of neutralizing antibodies to block tumor growth
1992 • 147 citations
Transforming growth factor beta1 is a target for the von Hippel-Lindau tumor suppressor and a critical growth factor for clear cell renal carcinoma.
1999 • 147 citations
Smad4/DPC4 Silencing and Hyperactive Ras Jointly Disrupt Transforming Growth Factor-β Antiproliferative Responses in Colon Cancer Cells
1999 • 146 citations
A soluble transforming growth factor beta type III receptor suppresses tumorigenicity and metastasis of human breast cancer MDA-MB-231 cells.
1999 • 116 citations
Role of interleukin 10 and transforming growth factor beta1 in the angiogenesis and metastasis of human prostate primary tumor lines from orthotopic implants in severe combined immunodeficiency mice.
1999 • 116 citations
Epithelioid sarcoma: a clinicopathologic and prognostic study of 26 cases.
1993 • 111 citations
Positive correlation of plasma transforming growth factor-β1 levels with tumor vascularity in hepatocellular carcinoma
1995 • 96 citations
Concerted action of TGF-beta 1 and its type II receptor in control of epidermal homeostasis in transgenic mice.
1995 • 96 citations
Transforming growth factor-β-mediated autocrine growth regulation of gliomas as detected with phosphorothioate antisense oligonucleotides
1996 • 88 citations
Transforming growth factors β
1989 • 86 citations
Synthesis and degradation of basement membranes and extracellular matrix and their regulation by TGF-β in invasive carcinomas (Review)
2001 • 85 citations
Transforming growth factor β1 is implicated in the failure of tamoxifen therapy in human breast cancer
1991 • 84 citations
Blockade of Smad4 in transformed keratinocytes containing a Ras oncogene leads to hyperactivation of the Ras-dependent Erk signalling pathway associated with progression to undifferentiated carcinomas
2000 • 78 citations
Tumorigenicity of mouse thymoma is suppressed by soluble type II transforming growth factor beta receptor therapy.
1999 • 77 citations
Reversal of Tamoxifen Resistance of Human Breast Carcinomas In Vivo by Neutralizing Antibodies to Transforming Growth Factor-
1999 • 76 citations
Effects of transforming growth factor β on growth of human mammary epithelial cells in culture
1989 • 76 citations
Modulation of B16 Melanoma Growth and Metastasis by Anti-Transforming Growth Factor ?? Antibody and Interleukin-2
1996 • 59 citations
Involvement of the Ras/MAPK Signaling Pathway in the Modulation of Urokinase Production and Cellular Invasiveness by Transforming Growth Factor-β1 in Transformed Keratinocytes
2000 • 56 citations
Evidence That Smad2 Is a Tumor Suppressor Implicated in the Control of Cellular Invasion
1999 • 47 citations
Epithelial-mesenchymal transformation of a newly established cell line from ovarian adenosarcoma by transforming growth factor-Β1
1996 • 37 citations
Blockade of Transforming Growth Factor-β Signaling Does Not Abrogate Antiestrogen-induced Growth Inhibition of Human Breast Carcinoma Cells
1997 • 35 citations